text,labels
Normal weight - showed subjects blood significant oxygen level dependent - responses in the prefrontal ventromedial cortex () vmPFC to food aromas compared responses with by induced the odor inedible of an object.,3
Normal weight subjects - blood showed significant oxygen level - dependent in responses the ventromedial prefrontal (cortex vmPFC to) food compared aromas with responses induced by the odor of inedible object an.,3
Normal - subjects weight showed significant blood level oxygen - dependent responses ventromedial in the cortex prefrontal () vmPFC to food aromas compared with induced responses by the an of odor inedible object.,3
Normal - subjects weight showed oxygen significant blood level - responses dependent the in prefrontal cortex ventromedial (vmPFC) to food aromas with induced compared responses by the odor of an inedible object.,3
Normal - showed weight subjects significant oxygen blood level - responses dependent the in ventromedial prefrontal cortex () vmPFC to food aromas compared with induced responses the odor by of an object inedible.,3
Normal - subjects weight showed significant blood oxygen level - dependent in responses the ventromedial cortex prefrontal (vmPFC) food to aromas with compared induced responses the by odor of an inedible. object,3
: female 6 35. %.,3
: female. 35% 6.,3
: female 6 35. %.,3
: female. 35% 6.,3
: female. 6 35%.,3
35 female: .% 6.,3
"PrEP is efficacious for HIV - 1 women prevention using among and DMPA men whose use partners DMPA suggesting, PrEP could the mitigate increased potential HIV - 1 acquisition and transmission risks have that been associated DMPA with use.",4
"PrEP is efficacious for HIV 1 - prevention among women using men DMPA whose and partners DMPA use, suggesting PrEP could mitigate the potential increased HIV - and 1 acquisition transmission that risks have been associated use with DMPA.",4
"PrEP efficacious is for HIV - 1 prevention women using among DMPA men and partners whose use DMPA, PrEP suggesting could mitigate the potential increased HIV 1 - and acquisition transmission risks that have been associated with DMPA use.",4
"PrEP for is efficacious HIV - 1 prevention among DMPA women using whose and men partners use DMPA, suggesting PrEP could mitigate the potential increased HIV - 1 and transmission acquisition risks that been associated have with DMPA use.",4
"is PrEP for efficacious HIV - 1 prevention among women using DMPA and whose men partners DMPA use, suggesting PrEP could mitigate the potential HIV increased - 1 acquisition transmission and risks have that been with associated DMPA use.",4
"is PrEP for efficacious HIV - 1 prevention among using women DMPA and whose men partners use DMPA, PrEP suggesting mitigate could the increased potential HIV 1 - and acquisition transmission risks that been have associated with DMPA use.",4
"The SSM 30 g effective may be an, to noninvasive health alternative care provider - administered intravenous, intramuscular, or oral for opioids the management moderate of - to acute - severe pain.",4
"The SSM g 30 be may an effective, noninvasive to alternative health care - provider intravenous administered, intramuscular, oral or opioids for the management moderate of - to - severe pain acute.",4
"The 30 SSM may g effective be an, alternative noninvasive to health care - provider administered intravenous, intramuscular or, oral opioids for the management of moderate - to - severe pain acute.",4
"The SSM 30 g may be an effective, noninvasive alternative health to provider care - administered intravenous, intramuscular or, opioids oral management for of the moderate - to - severe pain acute.",4
"SSM the g 30 may be an effective, noninvasive alternative health to care provider - administered intravenous, , intramuscular or opioids oral for the management of moderate - to - severe pain acute.",4
"the SSM 30 g may be an effective, noninvasive alternative to health care - provider administered intravenous intramuscular, or, opioids oral the for management of moderate - to - severe pain acute.",4
